Author
Steven C Katz, MD, FACS Associate Professor of Surgery, Boston University School of Medicine; Director, Office of Therapeutic Development, Director of Complex General Surgical Oncology Fellowship, Director of Surgical Immunotherapy, Roger Williams Medical Center
Steven C Katz, MD, FACS is a member of the following medical societies: American Association for Cancer Research, American Association of Immunologists, American College of Surgeons, American Society of Clinical Oncology, Association for Academic Surgery, New England Surgical Society, Society for Immunotherapy of Cancer, Society for Leukocyte Biology, Society of Surgical Oncology, Society of University Surgeons
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: TNK and Surefire<br/>Serve(d) as a speaker or a member of a speakers bureau for: Merck<br/>Received research grant from: TNK and Surefire.
Coauthor(s)
Ayana Allard-Picou, MD Fellow in Surgical Oncology, Department of Surgery, Roger Williams Medical Center
Ayana Allard-Picou, MD is a member of the following medical societies: American College of Surgeons, American Medical Student Association/Foundation, Christian Medical and Dental Associations, Golden Key International Honour Society, Pennsylvania Medical Society, Sentinel Lymph Node Working Group, Society of Surgical Oncology
Disclosure: Nothing to disclose.
Specialty Editor Board
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Chief Editor
Edwin Choy, MD, PhD Assistant Professor of Medicine, Harvard Medical School; Director of Sarcoma Clinical Research, Clinical Director of Sarcoma Oncology, Department of Medicine, Division of Hematology/Oncology, Dana Farber/Harvard Cancer Center, Massachusetts General Hospital
Edwin Choy, MD, PhD is a member of the following medical societies: American Society of Clinical Oncology, Children's Oncology Group, Connective Tissue Oncology Society, Radiation Therapy Oncology Group, Sarcoma Alliance for Research through Collaboration
Disclosure: Received research grant from: Amgen, Mirati, Novartis, Eli Lilly, Exelexis, Astra Zeneca, Iterion, and IMDZ<br/>Received income in an amount equal to or greater than $250 from: Immunodesign.
Additional Contributors
Mariclaire Cloutier Freelance editor, Medscape Drugs & Diseases
Disclosure: Nothing to disclose.
